On Monday, several dozen members of the public are lined up outside 100 Centre Street in Lower Manhattan, hoping to squeeze ...
The Global Life Sciences BPO Market Size projected to grow at a CAGR of 7.50% from 2026 to 2032, according to a new report published ...
Dan brings more than 30 years of leadership experience in biotechnology and oncology, with a proven track-record of creating ...
Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses([1]) , while ...
Issued on behalf of GT Biopharma, Inc.USA News Group News CommentaryVANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination ...
ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announced today that ...
CNW/ -- (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient ...
The Phase II OCULE-01 study in uveal melanoma started in March 2025, the PULMO-01 study in non-small cell lung cancer (NSCLC) started in May 2025 and the HEMA-MED Phase I/II study in myelofibrosis ...
Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate ...
Testing by Rutgers Health and other institutions is reshaping how – and how gently – doctors repair failing valves ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback